Copper Oxide Nanoparticles as Dual-Action Inhibitors of Biofilm Formation and Virulence in Candida albicans and Proteus mirabilis
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Antifungal resistance and susceptibility · Bacterial biofilms and quorum sensing · Nanoparticles: synthesis and applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (71)
Show source-provided references
1. Uruén C, Chopo-Escuin G, Tommassen J, Mainar-Jaime RC, Arenas J (2021) Biofilms as promoters of bacterial antibiotic resistance and tolerance. Antibiotics 10:3. https://doi.org/10.3390/antibiotics1001000310.3390/antibiotics10010003 ↗
2. Zhang K, Li X, Yu C, Wang Y (2020) Promising therapeutic strategies against microbial biofilm challenges. Front Cell Infect Microbiol 10. https://doi.org/10.3389/fcimb.2020.0035910.3389/fcimb.2020.00359 ↗
3. Khan J, Tarar SM, Gul I, Nawaz U, Arshad M (2021) Challenges of antibiotic resistance biofilms and potential combating strategies: a review. Biotech 11:169. https://doi.org/10.1007/s13205-021-02707-w10.1007/s13205-021-02707-w ↗
4. Sharma D, Misba L, Khan AU (2019) Antibiotics versus biofilm: an emerging battleground in microbial communities. Antimicrob Resist Infect Control 8:76. https://doi.org/10.1186/s13756-019-0533-310.1186/s13756-019-0533-3 ↗
5. Cendra MDM, Torrents E (2021) Pseudomonas aeruginosa biofilms and their partners in crime. Biotechnol Adv 49:107734. https://doi.org/10.1016/j.biotechadv.2021.10773410.1016/j.biotechadv.2021.107734 ↗
6. Yin W, Wang Y, Liu L, He J (2019) Biofilms: The microbial "Protective Clothing" in extreme environments. Int J Mol Sci 20. https://doi.org/10.3390/ijms2014342310.3390/ijms20143423 ↗
7. Balcázar JL, Subirats J, Borrego CM (2015) The role of biofilms as environmental reservoirs of antibiotic resistance. Front Microbiol 6. https://doi.org/10.3389/fmicb.2015.0121610.3389/fmicb.2015.01216 ↗
8. Burmølle M, Thomsen TR, Fazli M, Dige I, Christensen L, Homøe P, Tvede M, Nyvad B, Tolker-Nielsen T, Givskov M et al (2010) Biofilms in chronic infections – a matter of opportunity – monospecies biofilms in multispecies infections. FEMS Immunol Med Microbiol 59:324–336. https://doi.org/10.1111/j.1574-695X.2010.00714.x10.1111/j.1574-695X.2010.00714.x ↗
9. Liu HY, Prentice EL, Webber MA (2024) Mechanisms of antimicrobial resistance in biofilms. Npj Antimicrob Resist 2:27. https://doi.org/10.1038/s44259-024-00046-310.1038/s44259-024-00046-3 ↗
10. Vestby LK, Grønseth T, Simm R, Nesse LL (2020) Bacterial biofilm and its role in the pathogenesis of disease. Antibiotics (Basel) 9. https://doi.org/10.3390/antibiotics902005910.3390/antibiotics9020059 ↗
11. Rumbaugh KP, Sauer K (2020) Biofilm dispersion. Nat Rev Microbiol 18:571–586. https://doi.org/10.1038/s41579-020-0385-010.1038/s41579-020-0385-0 ↗
12. Li X, Sun L, Zhang P, Wang Y (2021) Novel approaches to combat medical device-associated BioFilms. Coatings 11:294. https://doi.org/10.3390/coatings1103029410.3390/coatings11030294 ↗
13. Wasfi R, Hamed SM, Amer MA, Fahmy LI (2020) Proteus mirabilis biofilm: Development and therapeutic strategies. Front Cell Infect Microbiol 10. https://doi.org/10.3389/fcimb.2020.0041410.3389/fcimb.2020.00414 ↗
14. Armbruster CE, Mobley HLT, Pearson MM (2018) Pathogenesis of Proteus mirabilis infection. EcoSal Plus 8. https://doi.org/10.1128/ecosalplus.ESP-0009-201710.1128/ecosalplus.ESP-0009-2017 ↗
15. Mobley HLT (2019) Proteus mirabilis overview. Methods Mol Biol 2021:1–4. https://doi.org/10.1007/978-1-4939-9601-8_110.1007/978-1-4939-9601-8_1 ↗
16. Schaffer JN, Pearson MM (2015) Proteus mirabilis and Urinary Tract Infections. Microbiol Spectr 3. https://doi.org/10.1128/microbiolspec.UTI-0017-201310.1128/microbiolspec.UTI-0017-2013 ↗
17. Hola V, Peroutkova T, Ruzicka F (2012) Virulence factors in Proteus bacteria from biofilm communities of catheter-associated urinary tract infections. FEMS Immunol Med Microbiol 65:343–349. https://doi.org/10.1111/j.1574-695X.2012.00976.x10.1111/j.1574-695X.2012.00976.x ↗
18. Ponde NO, Lortal L, Ramage G, Naglik JR, Richardson JP (2021) Candida albicans biofilms and polymicrobial interactions. Crit Rev Microbiol 47:91–111. https://doi.org/10.1080/1040841x.2020.184340010.1080/1040841x.2020.1843400 ↗
19. Lopes JP, Lionakis MS (2022) Pathogenesis and virulence of Candida albicans. Virulence 13:89–121. https://doi.org/10.1080/21505594.2021.201995010.1080/21505594.2021.2019950 ↗
20. Staniszewska M (2020) Virulence factors in Candida species. Curr Protein Pept Sci 21:313–323. https://doi.org/10.2174/138920372066619072215241510.2174/1389203720666190722152415 ↗
21. Pereira R, Dos Santos Fontenelle RO, de Brito EHS, de Morais SM (2021) Biofilm of Candida albicans: formation, regulation and resistance. J Appl Microbiol 131:11–22. https://doi.org/10.1111/jam.1494910.1111/jam.14949 ↗
22. Nadar S, Khan T, Patching SG, Omri A (2022) Development of antibiofilm therapeutics strategies to overcome antimicrobial drug resistance. Microorganisms 10. https://doi.org/10.3390/microorganisms1002030310.3390/microorganisms10020303 ↗
23. Wasfi R, Hamed SM, Amer MA, Fahmy LI (2020) Proteus mirabilis Biofilm: development and therapeutic strategies. Front Cell Infect Microbiol 10:414. https://doi.org/10.3389/fcimb.2020.0041410.3389/fcimb.2020.00414 ↗
24. Li B, Pan L, Zhang H, Xie L, Wang X, Shou J, Qi Y, Yan X (2021) Recent developments on using nanomaterials to combat Candida albicans. Front Chem 9:813973. https://doi.org/10.3389/fchem.2021.81397310.3389/fchem.2021.813973 ↗
25. Qureshi et al. (2024) Nanoparticle-mediated disruption of biofilms in bacterial pathogens. Microb Pathog 106546. https://doi.org/10.1016/j.micpath.2024.10654610.1016/j.micpath.2024.106546 ↗
26. Kumari et al. (2024) Nanoparticles as antibiofilm agents: current progress and future prospects. Appl Microbiol Biotechnolhttps://doi.org/10.1007/s00253-024-13050-410.1007/s00253-024-13050-4 ↗
27. Saleem et al. (2024) Antibiofilm mechanisms and ROS generation by nanoparticles against multidrug-resistant pathogens. Microb Pathog 106658. https://doi.org/10.1016/j.micpath.2024.10665810.1016/j.micpath.2024.106658 ↗
28. Rizwana et al. (2024) Recent advances in nanoparticles targeting bacterial biofilms. Biofilm 100192. https://doi.org/10.1016/j.bioflm.2024.10019210.1016/j.bioflm.2024.100192 ↗
29. Mamun MM, Sorinolu AJ, Munir M, Vejerano EP (2021) Nanoantibiotics: Functions and properties at the nanoscale to combat antibiotic resistance. Front Chem 9. https://doi.org/10.3389/fchem.2021.68766010.3389/fchem.2021.687660 ↗
30. Ozdal M, Gurkok S (2022) Recent advances in nanoparticles as antibacterial agent. Admet dmpk 10:115–129. https://doi.org/10.5599/admet.117210.5599/admet.1172 ↗
31. Erci F, Cakir-Koc R, Yontem M, Torlak E (2020) Synthesis of biologically active copper oxide nanoparticles as promising novel antibacterial-antibiofilm agents. Prep Biochem Biotechnol 50:538–548. https://doi.org/10.1080/10826068.2019.171139310.1080/10826068.2019.1711393 ↗
32. Padmavathi AR, Sriyutha Murthy P, Das A, Nishad PA, Pandian R, Rao TS (2019) Copper oxide nanoparticles as an effective anti-biofilm agent against a copper tolerant marine bacterium, Staphylococcus lentus. Biofouling 35:1007–1025. https://doi.org/10.1080/08927014.2019.168768910.1080/08927014.2019.1687689 ↗
33. Bai B, Saranya S, Dheepaasri V, Muniasamy S, Alharbi NS, Selvaraj B, Undal VS, Gnanamangai BM (2022) Biosynthesized copper oxide nanoparticles (CuO NPs) enhances the anti-biofilm efficacy against K. pneumoniae and S. aureus. J King Saud Univ-Sci 34:102120. https://doi.org/10.1016/j.jksus.2022.10212010.1016/j.jksus.2022.102120 ↗
34. Ansarifard E, Zareshahrabadi Z, Sarafraz N, Zomorodian K (2021) Evaluation of antimicrobial and antibiofilm activities of copper oxide nanoparticles within soft denture liners against oral pathogens. Bioinorg Chem Appl 2021:9939275. https://doi.org/10.1155/2021/993927510.1155/2021/9939275 ↗
35. Mohamed AA, Abu-Elghait M, Ahmed NE, Salem SS (2021) Eco-friendly mycogenic synthesis of ZnO and CuO nanoparticles for in vitro antibacterial, antibiofilm, and antifungal applications. Biol Trace Elem Res 199:2788–2799. https://doi.org/10.1007/s12011-020-02369-410.1007/s12011-020-02369-4 ↗
36. Agarwala M, Choudhury B, Yadav RN (2014) Comparative study of antibiofilm activity of copper oxide and iron oxide nanoparticles against multidrug resistant biofilm forming uropathogens. Indian J Microbiol 54:365–368. https://doi.org/10.1007/s12088-014-0462-z10.1007/s12088-014-0462-z ↗
37. Verma N, Kumar N (2019) Synthesis and biomedical applications of copper oxide nanoparticles: an expanding horizon. ACS Biomater Sci Eng 5:1170–1188. https://doi.org/10.1021/acsbiomaterials.8b0109210.1021/acsbiomaterials.8b01092 ↗
38. Joshi KM, Shelar A, Kasabe U, Nikam LK, Pawar RA, Sangshetti J, Kale BB, Singh AV, Patil R, Chaskar MG (2022) Biofilm inhibition in Candida albicans with biogenic hierarchical zinc-oxide nanoparticles. Biomater Adv 134:112592. https://doi.org/10.1016/j.msec.2021.11259210.1016/j.msec.2021.112592 ↗
39. Mugita Y, Nakagami G, Minematsu T, Kitamura A, Sanada H (2020) Combination of urease inhibitor and antiseptic inhibits urea decomposition-induced ammonia production by Proteus mirabilis. Int Wound J 17:1558–1565. https://doi.org/10.1111/iwj.1342210.1111/iwj.13422 ↗
40. Sivasankar C, Maruthupandiyan S, Balamurugan K, James PB, Krishnan V, Pandian SK (2016) A combination of ellagic acid and tetracycline inhibits biofilm formation and the associated virulence of Propionibacterium acnes in vitro and in vivo. Biofouling 32:397–410. https://doi.org/10.1080/08927014.2016.114814110.1080/08927014.2016.1148141 ↗
41. Masuko T, Minami A, Iwasaki N, Majima T, Nishimura S-I, Lee YC (2005) Carbohydrate analysis by a phenol–sulfuric acid method in microplate format. Anal Biochem 339:69–72. https://doi.org/10.1016/j.ab.2004.12.00110.1016/j.ab.2004.12.001 ↗
42. Al-Qahtani M, Safan A, Jassim G, Abadla S (2019) Efficacy of anti-microbial catheters in preventing catheter associated urinary tract infections in hospitalized patients: A review on recent updates. J Infect Public Health 12:760–766. https://doi.org/10.1016/j.jiph.2019.09.00910.1016/j.jiph.2019.09.009 ↗
43. Bergamo VZ, Donato RK, Dalla Lana DF, Donato KJZ, Ortega GG, Schrekker HS, Fuentefria AM (2015) Imidazolium salts as antifungal agents: strong antibiofilm activity against multidrug-resistant Candida tropicalis isolates. Lett Appl Microbiol 60:66–71. https://doi.org/10.1111/lam.1233810.1111/lam.12338 ↗
44. Sahal G, Bilkay I (2015) Multidrug resistance by biofilm-forming clinical strains of Proteus mirabilis. Multidrug Resist Biofilm-Forming Clin Strains Proteus Mirabilis 9:535–541. https://doi.org/10.5372/1905-7415.0904.42410.5372/1905-7415.0904.424 ↗
45. Li H, Yang Z, Khan SA, Walsh LJ, Seneviratne CJ, Ziora ZM (2024) Characteristics of metallic nanoparticles (Especially Silver Nanoparticles) as anti-biofilm agents. Antibiotics 13:819. https://doi.org/10.3390/antibiotics1309081910.3390/antibiotics13090819 ↗
46. Wang H, Li Y, Chen X, Liu Y, Zhao C (2023) Physicochemical properties determining the antibiofilm efficacy of copper oxide nanoparticles against Proteus mirabilis. Coll Surf B: Biointerfaceshttps://doi.org/10.1016/j.colsurfb.2023.11287610.1016/j.colsurfb.2023.112876 ↗
47. Zhang L, Jiang Y, Ding Y, Daskalakis N, Jeuken L (2023) Sonochemical synthesis of copper oxide nanoparticles: Effect of sonication parameters on particle characteristics and antibiofilm activity. Ultrason Sonochem. https://doi.org/10.1016/j.ultsonch.2022.10612310.1016/j.ultsonch.2022.106123 ↗
48. Ananth A, Dharaneedharan S, Heo MS, Mok YS (2023) Influence of synthesis method on structural and antimicrobial properties of CuO nanoparticles. Chem Eng Jhttps://doi.org/10.1016/j.cej.2022.07.05410.1016/j.cej.2022.07.054 ↗
49. Grainger DW, Castner DG (2021) Analytical methods for characterization of nanomaterial surfaces. Anal Bioanal Chem 413:2737–2740. https://doi.org/10.1007/s00216-021-03233-110.1007/s00216-021-03233-1 ↗
50. Wiesner MR, Colvin VL, Nel AE, Zink JI (2022) Current methods and prospects for analysis and characterization of nanomaterials in the environment. Environ Sci Technol 56(7):3558–3585. https://doi.org/10.1021/acs.est.1c0801110.1021/acs.est.1c08011 ↗
51. Alhumaimess MS, Essawy AA, Kamel MM, Alsohaimi IH, Hassan HMA (2020) Biogenic-mediated synthesis of mesoporous Cu(2)O/CuO nano-architectures of superior catalytic reductive towards nitroaromatics. nanomaterials (Basel) 10. https://doi.org/10.3390/nano1004078110.3390/nano10040781 ↗
52. Chen H, Zhou X, Ren B, Cheng L (2020) The regulation of hyphae growth in Candida albicans. Virulence 11:337–348. https://doi.org/10.1080/21505594.2020.174893010.1080/21505594.2020.1748930 ↗
53. Yu Q, Li J, Zhang Y, Wang Y, Liu L, Li M (2016) Inhibition of gold nanoparticles (AuNPs) on pathogenic biofilm formation and invasion to host cells. Sci Rep 6:26667. https://doi.org/10.1038/srep2666710.1038/srep26667 ↗
54. Norsworthy AN, Pearson MM (2017) From catheter to kidney stone: the Uropathogenic lifestyle of Proteus mirabilis. Trends Microbiol 25:304–315. https://doi.org/10.1016/j.tim.2016.11.01510.1016/j.tim.2016.11.015 ↗
55. Gul A, Fozia, Shaheen A, Ahmad I, Khattak B, Ahmad M, Ullah R, Bari A, Ali SS, Alobaid A et al. (2021) Green synthesis, characterization, enzyme inhibition, antimicrobial potential, and cytotoxic activity of plant mediated silver nanoparticle using Ricinus communis leaf and root extracts. Biomolecules 11. https://doi.org/10.3390/biom1102020610.3390/biom11020206 ↗
56. Ali S, Bacha M, Shah MR, Shah W, Kubra K, Khan A, Ahmad M, Latif A, Ali M (2021) Green synthesis of silver and gold nanoparticles using Crataegus oxyacantha extract and their urease inhibitory activities. Biotechnol Appl Biochem 68:992–1002. https://doi.org/10.1002/bab.201810.1002/bab.2018 ↗
57. Flemming H-C, Wingender J (2010) The biofilm matrix. Nat Rev Microbiol 8:623–633. https://doi.org/10.1038/nrmicro241510.1038/nrmicro2415 ↗
58. Limoli DH, Jones CJ, Wozniak DJ (2015) Bacterial extracellular polysaccharides in biofilm formation and function. Microbiol Spectr 3. https://doi.org/10.1128/microbiolspec.MB-0011-201410.1128/microbiolspec.MB-0011-2014 ↗
59. Qin L, Imamura Y, Watanabe H, Kida Y, Kuwano K (2013) Impaired capsular polysaccharide is relevant to enhanced biofilm formation and lower virulence in Streptococcus pneumoniae. J Infect Chemother 19:261–271. https://doi.org/10.1007/s10156-012-0495-310.1007/s10156-012-0495-3 ↗
60. Joshi N, Ngwenya BT, French CE (2022) Bacterial extracellular polymeric substance production increases in response to nanoparticle-induced oxidative stress. Environ Sci Nano 9(3):1089–1102. https://doi.org/10.1039/D1EN00953B10.1039/D1EN00953B ↗
61. Durgadevi R, Veera Ravi A, Alexpandi R, Krishnan Swetha T, Abirami G, Vishnu S, Karutha Pandian S (2019) Virulence targeted inhibitory effect of linalool against the exclusive uropathogen Proteus mirabilis. Biofouling 35:508–525. https://doi.org/10.1080/08927014.2019.161970410.1080/08927014.2019.1619704 ↗
62. Nobile CJ, Johnson AD (2023) Candida albicans biofilm formation and its clinical consequences. Annu Rev Microbiol 77:55–72. https://doi.org/10.1146/annurev-micro-041520-05464310.1146/annurev-micro-041520-054643 ↗
63. Chen H, Zhou X, Ren B, Cheng L (2020) The regulation of hyphae growth in Candida albicans. Virulence 11:337–348. https://doi.org/10.1080/21505594.2020.173320510.1080/21505594.2020.1733205 ↗
64. Norsworthy AN, Pearson MM (2017) From catheter to kidney stone: the uropathogenic lifestyle of Proteus mirabilis. Trends Microbiol 25:304–315. https://doi.org/10.1016/j.tim.2016.11.00210.1016/j.tim.2016.11.002 ↗
65. Ansarifard E, Tafazzoli-Shadpour M, Kazemzadeh-Narbat M, Haghighipour N, Vaziri AS, Kharaziha M (2021) Evaluation of antimicrobial and antibiofilm activities of copper oxide nanoparticles within soft denture liners against oral pathogens. Bioinorg Chem Appl 2021:9939275. https://doi.org/10.1155/2021/993927510.1155/2021/9939275 ↗
66. Padmavathi AR, PS M, Das A, Priya A, Sushmitha TJ, Pandian SK, Toleti SR (2020) Impediment to growth and yeast-to-hyphae transition in Candida albicansby copper oxide nanoparticles. Biofouling 36(1):56–72. https://doi.org/10.1080/08927014.2020.171537110.1080/08927014.2020.1715371 ↗
67. Ren G, Hu D, Cheng EW, Vargas-Reus MA, Reip P, Allaker RP (2009) Characterisation of copper oxide nanoparticles for antimicrobial applications. Int J Antimicrob Agents 33:587–590. https://doi.org/10.1016/j.ijantimicag.2008.12.00410.1016/j.ijantimicag.2008.12.004 ↗
68. Ameh T, Sayes CM (2019) The potential exposure and hazards of copper nanoparticles: a review. Environ Toxicol Pharmacol 71:103220. https://doi.org/10.1016/j.etap.2019.10322010.1016/j.etap.2019.103220 ↗
69. Lewinski N, Colvin V, Drezek R (2008) Cytotoxicity of nanoparticles. Small 4:26–49. https://doi.org/10.1002/smll.20070059510.1002/smll.200700595 ↗
70. Angelé-Martínez C, Ameer FS, Raval YS, Huang G, Tzeng TJ, Anker JN, Brumaghim JL (2022) Polyphenol effects on CuO-nanoparticle-mediated DNA damage, reactive oxygen species generation, and fibroblast cell death. In Vitro Toxicol 78:105252. https://doi.org/10.1016/j.tiv.2021.10525210.1016/j.tiv.2021.105252 ↗
71. Zuo C, Fan P, Hu C, Bu X (2024) One-dimensional copper oxide nanorods with potential anticancer effects against melanoma cells. Arabian Journal of Chemistry 17:105689. https://doi.org/10.1016/j.arabjc.2024.10568910.1016/j.arabjc.2024.105689 ↗